• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Researchers Develop New Global Estimate of Medicinal Plant Species and Conservation Status

    All Eyes on Vision Health

    Health Benefits of Vitamin K: A Contemporary Cornerstone of Heart and Bone Health

    Vitamin D: A Fixture of Supplementation and Fortification

    Magnesium: An Essential Mineral with Many Forms and Functions
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Glossary
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    Nutrasource Rebrands Clinical Trial Site to Apex Trials

    Kerry Sponsors Upcycled Food Foundation Research Fellowship

    Probiotics Supplementation Reduces Complications in Colorectal Cancer Patients

    Vitamin D Supplementation Reduces Risk of Dynapenia

    Sustained-Release Caffeine Ingredient Offers Mood, Performance Benefits
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    Natural Products Association Blasts FDA for Punting CBD Issues to Congress

    Probiotics Supplementation Reduces Complications in Colorectal Cancer Patients

    FDA Denies CBD Petitions, Cites Safety Concerns, Looks to Congress for New Regulatory Pathway

    Vitamin D Supplementation Reduces Risk of Dynapenia

    Sustained-Release Caffeine Ingredient Offers Mood, Performance Benefits
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    Nutrasource Rebrands Clinical Trial Site to Apex Trials

    Natural Products Association Blasts FDA for Punting CBD Issues to Congress

    Kerry Sponsors Upcycled Food Foundation Research Fellowship

    Probiotics Supplementation Reduces Complications in Colorectal Cancer Patients

    FDA Denies CBD Petitions, Cites Safety Concerns, Looks to Congress for New Regulatory Pathway
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Probiotics Supplementation Reduces Complications in Colorectal Cancer Patients

    Vitamin D Supplementation Reduces Risk of Dynapenia

    Sustained-Release Caffeine Ingredient Offers Mood, Performance Benefits

    Multi-Strain Probiotic Improves Self-Reported Mood, Sleep, Serotonin Levels

    CRN Highlights 'Supplement to Savings' Report for National Heart Month
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Bioenergy Life Science, Inc. (BLS)

    Nutrition21, LLC

    Gencor

    KLK OLEO

    EIRICH Machines
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Bioenergy Life Science, Inc. (BLS)

    Nutrition21, LLC

    Gencor

    KLK OLEO

    EIRICH Machines
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    ‘Prohibited Acts’ Provision Could Be Used to Target Law-Abiding Companies & Legit Dietary Ingredients

    On the surface, mandatory product listing sounds like a reasonable idea, but there’s more to consider.

    ‘Prohibited Acts’ Provision Could Be Used to Target Law-Abiding Companies & Legit Dietary Ingredients
    Related CONTENT
    • FDA Denies CBD Petitions, Cites Safety Concerns, Looks to Congress for New Regulatory Pathway
    • Sustained-Release Caffeine Ingredient Offers Mood, Performance Benefits
    • 2023 Expectations For Wellness, Supplements, CBD, and the Broader Economy
    • All Eyes on Vision Health
    • Health Benefits of Vitamin K: A Contemporary Cornerstone of Heart and Bone Health
    By Todd Harrison, Partner, Venable09.08.22
    The FDA recently issued its final guidance document on N-acetyl-cysteine (NAC), continuing to take the position that NAC is excluded from the definition of a dietary supplement. However, due to NAC’s long history of safe use over the past 30 years, the agency has decided to exercise enforcement discretion while it continues to evaluate whether to initiate rulemaking specifically permitting the sale of NAC as a dietary supplement. This decision is welcome news to the industry that believes FDA wrongly targeted NAC for exclusion.

    However, one must be wary of the proposed mandatory product listing (MPL) requirement, as well as its companion language, which specifically states that “[t]he introduction or delivery for introduction into interstate commerce of any product marketed as a dietary supplement that does not meet the definition of a dietary supplement under section 201(ff)” is a prohibited act.

    As an old proverb states, “the road to hell is paved with good intentions.” On the surface, MPL sounds like a reasonable idea. Proponents make the case that it offers transparency to the marketplace and provides FDA with information it needs to ensure requirements of the Dietary Supplement Health and Education Act (DSHEA) are effectively enforced. 

    These are good and honorable intentions. But most bad actors, including their manufacturers, are not going to register and list their products. Rather, only responsible companies will do so.  Yes, large retailers will be able to enforce this requirement by denying their marketplace to products that aren’t listed with FDA. Again, though, I doubt that bad actors will care.

    However, mandatory listing of all products and ingredients with FDA will give the agency the ability to enforce the preclusion provisions of DSHEA, as well as New Dietary Ingredient Notifications (NDIN) rather easily.

    Unfairly Targeting Responsible Companies

    “Come again? Todd, a few years ago you thought product listing was a good idea. Are you changing your mind?” Well, yes, because the prohibited acts provision can be used to unfairly target companies and ingredients while allowing the bad actors to continue down their merry path.

    Also, as presently structured, I do not see how MPL advances transparency, as it has no real teeth to it. The MPL is at best “feel good” legislation. Feel good legislation is where Congress pats itself on the back saying “we did something meaningful,” when in fact it just made life harder for a lot of law-abiding companies.

    Anyone who has bad allergies and congestion knows what I’m talking about when you are denied pseudoephedrine/antihistamine OTC drugs because Congress thought it would reduce the illicit meth trade. But all it did was make it harder for law-abiding citizens to get a drug that works while doing nothing to reduce the illicit meth trade.

    Unintended Consequences

    On to my examples of how this legislation that is presently fashioned creates unintended consequences.

    Putting aside that NAC would qualify as a grandfathered dietary ingredient but for the drug approval all those years ago, there has not been any showing that NAC was marketed as a dietary supplement prior to this approval. Now, FDA could readily identify those companies marketing NAC and, instead of sending warning letters, have the Department of Justice file a lawsuit—or worse, have DOJ institute a seizure action. Boom, there it is, NAC is removed quickly and effectively from the marketplace.

    Similarly, do you believe CBD would be on the market today if MPL is passed? Probably not, because FDA would have access to every major company that markets the product, and DOJ would be able to initiate seizure actions to remove it from the marketplace due to the significant drug trials conducted on CBD.

    However, manufacturers of designer supplements with highly questionable ingredients would continue to market their wares because FDA would not know where to find them. Similarly, vinpocetine would not be the subject of ongoing rulemaking, even though it has been marketed for at least the last 20 years, due to obscure trials in the 1980s. Here again, FDA would only need to do a quick search to find every company that is marketing vinpocetine supplements and decide which companies to target, because its burden is less. 

    Similarly, FDA would be able to query all new dietary ingredients (NDI). Anyone who’s read FDA’s position on when an NDI notification is required will know that upwards of 70% of dietary ingredients would likely be considered NDIs for which a notification is necessary.

    Here again, if the agency wanted to target certain NDIs, it could simply query the system and have a ready-made list—and many ingredients may not meet FDA’s narrowly defined term “for dietary substance.” Thus, once again, FDA would be able to target those companies. The problem is that the companies which should be targeted did not list their products with FDA in the first place. Thus, MPL, along with the prohibited acts language, would mainly impact legitimate companies as opposed to bad actors because it will be significantly easier to identify legitimate companies. 

    FDA’s Existing Authority

    So, what is the solution? Well, FDA needs to do its job. If FDA does not believe an ingredient is lawfully marketed, then it can take action, instead of taking forever to decide what to do while a marketplace grows around the new “it” ingredient. Yes, it may lose a few of those cases but the agency will also win many others.

    FDA has the authority now to act against questionable companies and dietary ingredients. But rather than doing its job, the agency wants all products listed and the new prohibited acts language it doesn’t really need to effectively regulate the marketplace. I see no reason to provide this additional authority until FDA uses its current authority.

    If the agency takes issue with an ingredient, then it can institute legal action today. There is no need for new authority to do that. If enforcement dollars are an issue, then ask for more funding.

    My fear is that the proposed legislation will do nothing to reduce the number of bad actors with questionable ingredients. Indeed, because of FDA’s “first bite of apple” approach to regulation, a company marketed honey adulterated with sildenafil or tadalafil. Here is a novel approach: seize the product because there is a real safety issue rather than send a warning letter. It should have been a no-brainer case.  

    With all that said, if MPL becomes a foregone conclusion, then at least make it easier to enforce against bad actors by adding language that if a manufacturer produces a product that is not listed with FDA, then all the products that manufacturer produces are to be considered adulterated as a matter of law.

    Place the onus on the manufacturer to ensure that all products are being listed. A massive recall is not in the manufacturer’s best interest.

    Finally, the prohibited acts provision is unnecessary as FDA has the authority to enforce existing statute. Squabbles between who should enforce—the Center for Food Safety and Applied Nutrition (CFSAN) or the Center for Drug Evaluation and Research (CDER)—need to stop. It shouldn’t matter because they belong to the same agency after all.

    If NAC has shown anything, what really needs to be changed is the preclusion provisions to consider dosage, route of administration, etc. in determining whether a dietary or food ingredient is precluded. We should also have a mechanism where the company that wishes to commercialize an ingredient as a dietary supplement can submit a notification to FDA showing it’s generally safe for consumption. I wrote an article on this issue previously titled “Understanding Exclusion (Preclusion) and a Proposed Solution.” It’s worth reviewing.

    Most of all, remember: “the road to hell is paved with good intentions.”


    About the Author: Todd Harrison is partner with Venable, which is located in Washington, D.C. He advises food and drug companies on a variety of FDA and FTC matters, with an emphasis on dietary supplement, functional food, biotech, legislative, adulteration, labeling and advertising issues. He can be reached at 575 7th St. NW, Washington, D.C. 20004, Tel: 202-344-4724; E-mail: taharrison@venable.com.
    Related Searches
    • Regulations
    • Dietary Supplements
    Related Knowledge Center
    • Dietary Supplements
    • Regulations
    Suggested For You
    FDA Denies CBD Petitions, Cites Safety Concerns, Looks to Congress for New Regulatory Pathway FDA Denies CBD Petitions, Cites Safety Concerns, Looks to Congress for New Regulatory Pathway
    Sustained-Release Caffeine Ingredient Offers Mood, Performance Benefits Sustained-Release Caffeine Ingredient Offers Mood, Performance Benefits
    Healthy, Clean Label Snacks and Nutrition Bars Help Fill Nutrient Gap Cleaved By Modern Lifestyles Healthy, Clean Label Snacks and Nutrition Bars Help Fill Nutrient Gap Cleaved By Modern Lifestyles
    Vitamin D: A Fixture of Supplementation and Fortification Vitamin D: A Fixture of Supplementation and Fortification
    Health Benefits of Vitamin K: A Contemporary Cornerstone of Heart and Bone Health Health Benefits of Vitamin K: A Contemporary Cornerstone of Heart and Bone Health
    2023 Expectations For Wellness, Supplements, CBD, and the Broader Economy 2023 Expectations For Wellness, Supplements, CBD, and the Broader Economy
    All Eyes on Vision Health All Eyes on Vision Health
    Top Gum Launches Sugar-Free Organic Gummies Top Gum Launches Sugar-Free Organic Gummies
    Pharmactive Launches Kiwi Extract Designed to Improve Protein Absorption Pharmactive Launches Kiwi Extract Designed to Improve Protein Absorption
    Protecting Your Brand and Reputation: The Keys to Avoiding Product Recalls Protecting Your Brand and Reputation: The Keys to Avoiding Product Recalls
    Black Seed Oil and Astaxanthin Formula Linked to Fewer Respiratory Complaints, Better Mood Black Seed Oil and Astaxanthin Formula Linked to Fewer Respiratory Complaints, Better Mood
    Gnosis Relaunches Adonat SAMe Ingredient Gnosis Relaunches Adonat SAMe Ingredient
    What to Expect from Investment and M&A Activity in the Vitamin, Mineral, Supplement Industry What to Expect from Investment and M&A Activity in the Vitamin, Mineral, Supplement Industry
    Fucoidan Supplier Marinova Marks 20 Years of Marine Biotechnology Fucoidan Supplier Marinova Marks 20 Years of Marine Biotechnology
    Kerry Appoints Bruce Brown as VP of Supplements in North America Kerry Appoints Bruce Brown as VP of Supplements in North America

    Related Online Exclusives

    • Dietary Supplements | Herbs & Botanicals | Regulations
      FDA Denies CBD Petitions, Cites Safety Concerns, Looks to Congress for New Regulatory Pathway

      FDA Denies CBD Petitions, Cites Safety Concerns, Looks to Congress for New Regulatory Pathway

      In response letters, agency says NDI process not robust enough to ensure applicable safety standards are met.
      By Sean Moloughney, Editor 01.26.23

    • Breaking News | Delivery & Dosage Technologies | Energy | Herbs & Botanicals | Research | Research News
      Sustained-Release Caffeine Ingredient Offers Mood, Performance Benefits

      Sustained-Release Caffeine Ingredient Offers Mood, Performance Benefits

      Compared to a standard caffeine supplement, Nutriventia’s CaffXtend resulted in a longer peak time, and significant improvements in self-reported effects.
      01.25.23

    • Consumer Trends | Dietary Supplements | Healthcare Trends | Regulations
      2023 Expectations For Wellness, Supplements, CBD, and the Broader Economy

      2023 Expectations For Wellness, Supplements, CBD, and the Broader Economy

      Even amid a slowdown, consumer focus on health and wellness appears to be a fixture in the current economy.
      By Sean Moloughney, Editor 01.20.23


    • Antioxidants | Dietary Supplements | Eye Health | Healthcare Trends | Herbs & Botanicals
      All Eyes on Vision Health

      All Eyes on Vision Health

      Nutrition solutions are targeting unique challenges to eye health from the blue light of ubiquitous screens.
      By Sean Moloughney, Editor 01.20.23

    • Bone & Joint Health | Cardiovascular Health | Dietary Supplements | Healthcare Trends | Research | Vitamins
      Health Benefits of Vitamin K: A Contemporary Cornerstone of Heart and Bone Health

      Health Benefits of Vitamin K: A Contemporary Cornerstone of Heart and Bone Health

      Clinical research is revealing overlooked health benefits of the micronutrient.
      By Mike Montemarano, Associate Editor 01.20.23

    Loading, Please Wait..
    Trending
    • NOW Switches To Bottles Made From 100% Post-Consumer Recycled Resin
    • Shiitake Mushroom Extract Appears Helpful In HPV Infections
    • The Functional Chocolate Company Launches Painfree Chocolate
    Breaking News
    • Nutrasource Rebrands Clinical Trial Site to Apex Trials
    • Kerry Sponsors Upcycled Food Foundation Research Fellowship
    • Probiotics Supplementation Reduces Complications in Colorectal Cancer Patients
    • Vitamin D Supplementation Reduces Risk of Dynapenia
    • Sustained-Release Caffeine Ingredient Offers Mood, Performance Benefits
    View Breaking News >
    CURRENT ISSUE

    Jan/Feb 2023

    • Healthy, Clean Label Snacks and Nutrition Bars Help Fill Nutrient Gap Cleaved By Modern Lifestyles
    • Magnesium: An Essential Mineral with Many Forms and Functions
    • Vitamin D: A Fixture of Supplementation and Fortification
    • Health Benefits of Vitamin K: A Contemporary Cornerstone of Heart and Bone Health
    • All Eyes on Vision Health
    • Researchers Develop New Global Estimate of Medicinal Plant Species and Conservation Status
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Nutrasource Rebrands Clinical Trial Site to Apex Trials
    Kerry Sponsors Upcycled Food Foundation Research Fellowship
    Probiotics Supplementation Reduces Complications in Colorectal Cancer Patients
    Coatings World

    Latest Breaking News From Coatings World

    Epoxytec Announces New Website Launch
    Paints and Coatings Market Worth $212B by 2026: MarketsandMarkets
    Axalta Releases Fourth Quarter and Full Year 2022 Results
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA OKs Tidepool Loop App Connecting CGMs, Insulin Pumps
    GE HealthCare, Imricor Team Up for Interventional Cardiac MRI
    Promising Study Results Released for Uncontrolled Hypertension Treatment
    Contract Pharma

    Latest Breaking News From Contract Pharma

    SK bioscience Introduces New Global Partnership Model for Vaccines
    Merck's KEYTRUDA Wins Expanded Approval in Non-Small Cell Lung Cancer
    Bone Biologics Engages Avania for NB1 Clinical Trial
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    LVMH Reports Record 2022
    Haircare Brand Uncle Funky’s Daughter Announces Retail Expansion
    TRESemmé Introduces New Pro Infusion Collection
    Happi

    Latest Breaking News From Happi

    Scott’s Liquid Gold Sells Wood and Floor Care Brands
    Ingredient Platform ClearForMe Expands into Baby Care
    Existing Regulatory Framework for Foods & Supplements Not Appropriate for CBD: FDA
    Ink World

    Latest Breaking News From Ink World

    Roland DGA Announces Major Expansion of TrueVIS Printer Family
    Neos Expands Production Capacity, European Market Presence
    Celanese Launches Nine New Conductive Inks for Consumer Applications
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Channeled Resources launches blank labels with PET liner
    Infigo partners with Four Pees in Benelux region
    EFI appoints Frank Pennisi CEO, Fiery now an independent business
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Essity’s Sales Grow
    Thinx to Pay up to $5 million to Settle Class Action Suit
    Typar Highlighting New Building Innovations
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Roche, Sysnav Partner on Movement Tracking Tech for Neuromuscular Disorders
    Orthopedic Braces/Support, Casting/Splints Market to Top $12B by 2030
    Orthofix Launches the Mariner Deformity System
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Celanese Launches Nine New Conductive Inks
    NREL Develops Thin, Lightweight Layer for Radiation Barrier for Perovskites in Space
    LG Display Reports Fourth Quarter 2022 Results

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login